Induction of metastatic gastric cancer by peroxisome proliferator-activated receptorδ activation

PPAR Research

Volumn , Issue , 2010, Pages

  Glazer, Robert I ^a   Pollock, Claire B ^a   Rodriguez, Olga ^a   Martin, Philip L ^b   Albanese, Chris ^a   Li, Xin ^a   Kopelovich, Levy ^c  

^a GEORGETOWN UNIVERSITY   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

^c NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

[2 METHYL 4 [4 METHYL 2 (4 TRIFLUOROMETHYLPHENYL) 5 THIAZOLYLMETHYLTHIO]PHENOXY]ACETIC ACID; BETA CATENIN; CALGRANULIN B; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR DELTA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR DELTA AGONIST; PHOSPHOINOSITIDE DEPENDENT PROTEIN KINASE 1; PROTEIN KINASE B;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CARCINOGENESIS; CELL ADHESION; CELL INVASION; FEMALE; INFLAMMATION; METABOLISM; METASTASIS; MOUSE; NONHUMAN; PROTEIN EXPRESSION; RECEPTOR INTRINSIC ACTIVITY; RECEPTOR UPREGULATION; STOMACH CANCER;

EID: 79952215111     PISSN: 16874757     EISSN: 16874765     Source Type: Journal    
DOI: 10.1155/2010/571783     Document Type: Article

References (76)

1. Lochhead P., El-Omar E. M. (Pubitemid 351398296)
2. Forman D., Burley V. J., Gastric cancer: global pattern of the disease and an overview of environmental risk factors Best Practice and Research: Clinical Gastroenterology 2006 20 4 633 649 (Pubitemid 44391336)
3. van Loon A. J. M., Botterweck A. A. M., Goldbohm R. A., Brants H. A. M., van Klaveren J. D., van den Brandt P. A., Intake of nitrate and nitrite and the risk of gastric cancer: a prospective cohort study British Journal of Cancer 1998 78 1 129 135 (Pubitemid 28276782)
4. Nishino Y., Inoue M., Tsuji I., Wakai K., Nagata C., Mizoue T., Tanaka K., Tsugane S., Tobacco smoking and gastric cancer risk: an evaluation based on a systematic review of epidemiologic evidence among the Japanese population Japanese Journal of Clinical Oncology 2006 36 12 800 807 (Pubitemid 47090736)
5. Eslick G. D., Helicobacter pylori infection causes gastric cancer? A review of the epidemiological, meta-analytic, and experimental evidence World Journal of Gastroenterology 2006 12 18 2991 2999 (Pubitemid 43811074)
6. El-Omar E. M., Role of host genes in sporadic gastric cancer Best Practice and Research: Clinical Gastroenterology 2006 20 4 675 686 (Pubitemid 44391334)
7. Barish G. D., Narkar V. A., Evans R. M., PPAR : a dagger in the heart of the metabolic syndrome Journal of Clinical Investigation 2006 116 3 590 597 (Pubitemid 43326863)
8. Berger J. P., Akiyama T. E., Meinke P. T., PPARs: therapeutic targets for metabolic disease Trends in Pharmacological Sciences 2005 26 5 244 251 (Pubitemid 40603072)
9. Glazer R. I., Yuan H., Xie Z., Yin Y., PPAR and PPAR as modulators of neoplasia and cell fate PPAR Research 2008 2008 8
10. Zang C., Wchter M., Liu H., Posch M. G., Fenner M. H., Stadelmann C., Von Deimling A., Possinger K., Black K. L., Koeffler H. P., Elstner E., Ligands for PPAR and RAR cause induction of growth inhibition and apoptosis in human glioblastomas Journal of Neuro-Oncology 2003 65 2 107 118 (Pubitemid 37521308)
11. Kopelovich L., Fay J. R., Glazer R. I., Crowell J. A., Peroxisome proliferator-activated receptor modulators as potential chemopreventive agents Molecular Cancer Therapeutics 2002 1 5 357 363
12. Michalik L., Desvergne B., Wahli W., Peroxisome-proliferator-activated receptors and cancers: complex stories Nature Reviews Cancer 2004 4 1 61 70 (Pubitemid 38082154)
13. Stephen R. L., Gustafsson M. C. U., Jarvis M., Tatoud R., Marshall B. R., Knight D., Ehrenborg E., Harris A. L., Wolf C. R., Palmer C. N. A., Activation of peroxisome proliferator-activated receptor stimulates the proliferation of human breast and prostate cancer cell lines Cancer Research 2004 64 9 3162 3170 (Pubitemid 38581418)
14. Gupta R. A., Tan J., Krause W. F., Geraci M. W., Willson T. M., Dey S. K., DuBois R. N., Prostacyclin-mediated activation of peroxisome proliferator-activated receptor in colorectal cancer Proceedings of the National Academy of Sciences of the United States of America 2000 97 24 13275 13280
15. Gupta R. A., Wang D., Katkuri S., Wang H., Dey S. K., DuBois R. N., Activation of nuclear hormone receptor peroxisome proliferator-activated receptor- accelerates intestinal adenoma growth Nature Medicine 2004 10 3 245 247 (Pubitemid 38667613)
16. Knutsen H. K., lstrn H. B., Paulsen J. E., Husy T., Goverud I. L., Lberg E. M., Kristiansen K., Alexander J., Increased levels of PPAR / and cyclin D1 in flat dysplastic ACF and adenomas in ApcMin/+ mice Anticancer Research 2005 25 6B 3781 3789 (Pubitemid 41665147)
17. Jaeckel E. C., Raja S., Tan J., Das S. K., Dey S. K., Girod D. A., Tsue T. T., Sanford T. R., Correlation of expression of cyclooxygenase-2, vascular endothelial growth factor, and peroxisome proliferator-activated receptor with head and neck squamous cell carcinoma Archives of OtolaryngologyHead and Neck Surgery 2001 127 10 1253 1259 (Pubitemid 32947457)
18. Suchanek K. M., May F. J., Lee W. J., Holman N. A., Roberts-Thomson S. J., Peroxisome proliferator-activated receptor expression in human breast epithelial cell lines of tumorigenic and non-tumorigenic origin International Journal of Biochemistry and Cell Biology 2002 34 9 1051 1058 (Pubitemid 34493766)
19. Yin Y., Russell R. G., Dettin L. E., Bai R., Wei Z. -L., Kozikowski A. P., Kopleovich L., Glazer R. I., Peroxisome proliferator-activated receptor and agonists differentially alter tumor differentiation and progression during mammary carcinogenesis Cancer Research 2005 65 9 3950 3957 (Pubitemid 40616378)
20. Wang D., Wang H., Guo Y., Ning W., Katkuri S., Wahli W., Desvergne B., Dey S. K., DuBois R. N., Crosstalk between peroxisome proliferator-activated receptor and VEGF stimulates cancer progression Proceedings of the National Academy of Sciences of the United States of America 2006 103 50 19069 19074 (Pubitemid 350002829)
21. Zuo X., Peng Z., Moussalli M. J., Morris J. S., Broaddus R. R., Fischer S. M., Shureiqi I., Targeted genetic disruption of peroxisome proliferator-activated receptor- and colonic tumorigenesis Journal of the National Cancer Institute 2009 101 10 762 767
22. Ghosh M., Ai Y., Narko K., Wang Z., Peters J. M., Hla T., PPAR is pro-tumorigenic in a mouse model of COX-2-induced mammary cancer Prostaglandins and Other Lipid Mediators 2009 88 3-4 97 100
23. Park B. H., Vogelstein B., Kinzler K. W., Genetic disruption of PPAR decreases the tumorigenicity of human colon cancer cells Proceedings of the National Academy of Sciences of the United States of America 2001 98 5 2598 2603 (Pubitemid 32209528)
24. Kwak H., Hwang I., Kim J. H., Kim M. Y., Yang J. S., Jeong S., Modulation of transcription by the peroxisome proliferator-activated receptor -binding RNA aptamer in colon cancer cells Molecular Cancer Therapeutics 2009 8 9 2664 2673
25. Shao J., Sheng H., DuBois R. N., Peroxisome proliferator-activated receptors modulate K-Ras-mediated transformation of intestinal epithelial cells Cancer Research 2002 62 11 3282 3288 (Pubitemid 34602426)
26. He T. C., Chan T. A., Vogelstein B., Kinzler K. W., PPAR is an APC-regulated target of nonsteroidal anti-inflammatory drugs Cell 1999 99 3 335 345 (Pubitemid 29519912)
27. Yu J., Leung W. K., Chen J., Ebert M. P. A., Malfertheiner P., Sung J. J. Y., Expression of peroxisome proliferator-activated receptor in human gastric cancer and its response to specific COX-2 inhibitor Cancer Letters 2005 223 1 11 17 (Pubitemid 40693706)
28. Yoshinaga M., Kitamura Y., Chaen T., Yamashita S., Tsuruta S., Hisano T., Ikeda Y., Sakai H., Nakamura K., Takayanagi R., Muto Y., The simultaneous expression of peroxisome proliferator-activated receptor delta and cyclooxygenase-2 may enhance angiogenesis and tumor venous invasion in tissues of colorectal cancers Digestive Diseases and Sciences 2009 54 5 1108 1114
29. Naruhn S., Meissner W., Adhikary T., Kaddatz K., Klein T., Watzer B., Mller-Brsselbach S., Mller R., 15-hydroxyeicosatetraenoic acid is a preferential peroxisome proliferator-activated receptor / agonist Molecular Pharmacology 2010 77 2 171 184
30. Piqueras L., Reynolds A. R., Hodivala-Dilke K. M., Alfranca A., Redondo J. M., Hatae T., Tanabe T., Warner T. D., Bishop-Bailey D., Activation of PPAR / induces endothelial cell proliferation and angiogenesis Arteriosclerosis, Thrombosis, and Vascular Biology 2007 27 1 63 69 (Pubitemid 46370477)
31. Wu C. W., Yu J., Sung J. J. Y., Peroxisome proliferator-activated receptor and gastric cancer (review) Oncology Reports 2009 22 3 451 457
32. Xu H. E., Lambert M. H., Montana V. G., Parks D. J., Blanchard S. G., Brown P. J., Sternbach D. D., Lehmann J. M., Wisely G. B., Willson T. M., Kliewer S. A., Milburn M. V., Molecular recognition of fatty acids by peroxisome proliferator-activated receptors Molecular Cell 1999 3 3 397 403 (Pubitemid 29290680)
33. Harman F. S., Nicol C. J., Marin H. E., Ward J. M., Gonzalez F. J., Peters J. M., Peroxisome proliferator-activated receptor- attenuates colon carcinogenesis Nature Medicine 2004 10 5 481 483 (Pubitemid 38667905)
34. Hollingshead H. E., Borland M. G., Billin A. N., Willson T. M., Gonzalez F. J., Peters J. M., Ligand activation of peroxisome proliferator-activated receptor- / (PPAR / ) and inhibition of cyclooxygenase 2 (COX2) attenuate colon carcinogenesis through independent signaling mechanisms Carcinogenesis 2008 29 1 169 176 (Pubitemid 351201756)
35. Marin H. E., Peraza M. A., Billin A. N., Willson T. M., Ward J. M., Kennett M. J., Gonzalez F. J., Peters J. M., Ligand activation of peroxisome proliferator-activated receptor inhibits colon carcinogenesis Cancer Research 2006 66 8 4394 4401
36. Peters J. M., Hollingshead H. E., Gonzalez F. J., Role of peroxisome-proliferator-activated receptor / (PPAR / ) in gastrointestinal tract function and disease Clinical Science 2008 115 3-4 107 127
37. Wei Z. L., Kozikowski A. P., A short and efficient synthesis of the pharmacological research tool GW501516 for the peroxisome proliferator-activated receptor Journal of Organic Chemistry 2003 68 23 9116 9118 (Pubitemid 37409567)
38. Fricke S. T., Rodriguez O., VanMeter J., Dettin L. E., Casimiro M., Chien C. D., Newell T., Johnson K., Ileva L., Ojeifo J., Johnson M. D., Albanese C., In vivo magnetic resonance volumetric and spectroscopic analysis of mouse prostate cancer models Prostate 2006 66 7 708 717
39. Yin Y., Yuan H., Zeng X., Kopelovich L., Glazer R. I., Inhibition of peroxisome proliferator-activated receptor increases estrogen receptor-dependent tumor specification Cancer Research 2009 69 2 687 694
40. Yin Y., Bai R., Russell R. G., Beildeck M. E., Xie Z., Kopelovich L., Glazer R. I., Characterization of medroxyprogesterone and DMBA-induced multilineage mammary tumors by gene expression profiling Molecular Carcinogenesis 2005 44 1 42 50 (Pubitemid 41216406)
41. Herschkowitz J. I., Simin K., Weigman V. J., Mikaelian I., Usary J., Hu Z., Rasmussen K. E., Jones L. P., Assefnia S., Chandrasekharan S., Backlund M. G., Yin Y., Khramtsov A. I., Bastein R., Quackenbush J., Glazer R. I., Brown P. H., Green J. E., Kopelovich L., Furth P. A., Palazzo J. P., Olopade O. I., Bernard P. S., Churchill G. A., Van Dyke T., Perou C. M., Identification of conserved gene expression features between murine mammary carcinoma models and human breast tumors Genome Biology 2007 8 5, article R76
42. Takahashi H., Shikata N., Senzaki H., Shintaku M., Tsubura A., Immunohistochemical staining patterns of keratins in normal oesophageal epithelium and carcinoma of the oesophagus Histopathology 1995 26 1 45 50
43. Chandra S. A., Nolan M. W., Malarkey D. E., Chemical carcinogenesis of the gastrointestinal tract in rodents: an overview with emphasis on NTP carcinogenesis bioassays Toxicologic Pathology 2010 38 1 188 197
44. Tomita H., Yamada Y., Oyama T., Hata K., Hirose Y., Hara A., Kunisada T., Sugiyama Y., Adachi Y., Linhart H., Mori H., Development of gastric tumors in ApcMin/+ mice by the activation of the -catenin/Tcf signaling pathway Cancer Research 2007 67 9 4079 4087 (Pubitemid 46815052)
45. Yamachika T., Nakanishi H., Inada K. I., Tsukamoto T., Shimizu N., Kobayashi K., Fukushima S., Tatematsu M., N-methyl-N-nitrosourea concentration-dependent, rather than total intake-dependent, induction of adenocarcinomas in the glandular stomach of BALB/c mice Japanese Journal of Cancer Research 1998 89 4 385 391 (Pubitemid 28226918)
46. Vauhkonen M., Vauhkonen H., Sipponen P., Pathology and molecular biology of gastric cancer Best Practice and Research: Clinical Gastroenterology 2006 20 4 651 674 (Pubitemid 44418021)
47. Oliver W. R., Shenk J. L., Snaith M. R., Russell C. S., Plunket K. D., Bodkin N. L., Lewis M. C., Winegar D. A., Sznaidman M. L., Lambert M. H., Xu H. E., Sternbach D. D., Kliewer S. A., Hansen B. C., Willson T. M., A selective peroxisome proliferator-activated receptor agonist promotes reverse cholesterol transport Proceedings of the National Academy of Sciences of the United States of America 2001 98 9 5306 5311 (Pubitemid 32397124)
48. Tanaka T., Yamamoto J., Iwasaki S., Asaba H., Hamura H., Ikeda Y., Watanabe M., Magoori K., Ioka R. X., Tachibana K., Watanabe Y., Uchiyama Y., Sumi K., Iguchi H., Ito S., Doi T., Hamakubo T., Naito M., Auwerx J., Yanagisawa M., Kodama T., Sakai J., Activation of peroxisome proliferator-activated receptor induces fatty acid -oxidation in skeletal muscle and attenuates metabolic syndrome Proceedings of the National Academy of Sciences of the United States of America 2003 100 26 15924 15929 (Pubitemid 38021091)
49. Palkar P. S., Borland M. G., Naruhn S., Ferry C. H., Lee C., Sk U. H., Sharma A. K., Amin S., Murray I. A., Anderson C. R., Perdew G. H., Gonzalez F. J., Mller R., Peters J. M., Cellular and pharmacological selectivity of the peroxisome proliferator-activated receptor- / antagonist GSK3787 Molecular Pharmacology 2010 78 3 419 430
50. Lee C. H., Chawla A., Urbiztondo N., Liao D., Boisvert W. A., Evans R. M., Transcriptional repression of atherogenic inflammation: modulation by PPAR Science 2003 302 5644 453 457 (Pubitemid 37296272)
51. Ali F., Ali N. S., Bauer A., Boyle J. J., Hamdulay S. S., Haskard D. O., Randi A. M., Mason J. C., PPAR and PGC1 act cooperatively to induce haem oxygenase-1 and enhance vascular endothelial cell resistance to stress Cardiovascular Research 2010 85 4 701 710
52. Pesant M., Sueur S., Dutartre P., Tallandier M., Grimaldi P. A., Rochette L., Connat J. L., Peroxisome proliferator-activated receptor (PPAR ) activation protects H9c2 cardiomyoblasts from oxidative stress-induced apoptosis Cardiovascular Research 2006 69 2 440 449 (Pubitemid 43098800)
53. Gebhardt C., Nmeth J., Angel P., Hess J., S100A8 and S100A9 in inflammation and cancer Biochemical Pharmacology 2006 72 11 1622 1631 (Pubitemid 44666730)
54. Ghavami S., Chitayat S., Hashemi M., Eshraghi M., Chazin W. J., Halayko A. J., Kerkhoff C., S100A8/A9: a Janus-faced molecule in cancer therapy and tumorgenesis European Journal of Pharmacology 2009 625 13 73 83
55. Glinghammar B., Skogsberg J., Hamsten A., Ehrenborg E., PPAR activation induces COX-2 gene expression and cell proliferation in human hepatocellular carcinoma cells Biochemical and Biophysical Research Communications 2003 308 2 361 368 (Pubitemid 36937188)
56. Han S., Ritzenthaler J. D., Wingerd B., Roman J., Activation of peroxisome proliferator-activated receptor / (PPAR / ) increases the expression of prostaglandin E receptor subtype EP4: the roles of phosphatidylinositol 3-kinase and CCAAT/enhancer-binding protein Journal of Biological Chemistry 2005 280 39 33240 33249 (Pubitemid 41397120)
57. Tan N. S., Michalik L., Noy N., Yasmin R., Pacot C., Heim M., Flhmann B., Desvergne B., Wahli W., Critical roles of PPAR / in keratinocyte response to inflammation Genes and Development 2001 15 24 3263 3277 (Pubitemid 34008192)
58. Oba M., Miwa K., Fujimura T., Harada S., Sasaki S., Oyama K., Ohta T., Hattori T., A selective cyclooxygenase-2 inhibitor prevents inflammation-related squamous cell carcinogenesis of the forestomach via duodenogastric reflux in rats Cancer 2009 115 2 454 464
59. Liu C. H., Chang S. H., Narko K., Trifan O. C., Wu M. T., Smith E., Haudenschild C., Lane T. F., Hla T., Overexpression of cyclooxygenase-2 is sufficient to induce tumorigenesis in transgenic mice Journal of Biological Chemistry 2001 276 21 18563 18569
60. Oshima M., Dinchuk J. E., Kargman S. L., Oshima H., Hancock B., Kwong E., Trzaskos J. M., Evans J. F., Taketo M. M., Suppression of intestinal polyposis in Apc(716) knockout mice by inhibition of cyclooxygenase 2 (COX-2) Cell 1996 87 5 803 809 (Pubitemid 26404280)
61. Bierie B., Moses H. L., Tumour microenvironment: TGF : the molecular Jekyll and Hyde of cancer Nature Reviews Cancer 2006 6 7 506 520 (Pubitemid 43980540)
62. Xu J., Lamouille S., Derynck R., TGF- -induced epithelial to mesenchymal transition Cell Research 2009 19 2 156 172
63. Prez-Lorenzo R., Markell L. M., Hogan K. A., Yuspa S. H., Glick A. B., Transforming growth factor 1 enhances tumor promotion in mouse skin carcinogenesis Carcinogenesis 2010 31 6 1116 1123
64. Tan N. S., Michalik L., Desvergne B., Wahli W., Genetic- or transforming growth factor- 1-induced changes in epidermal peroxisome proliferator-activated receptor / expression dictate wound repair kinetics Journal of Biological Chemistry 2005 280 18 18163 18170 (Pubitemid 41389061)
65. Tan N. S., Michalik L., Di-Po N., Ng C. Y., Mermod N., Roberts A. B., Desvergne B., Wahli W., Essential role of Smad3 in the inhibition of inflammation-induced PPAR / expression The EMBO Journal 2004 23 21 4211 4221 (Pubitemid 39546159)
66. Han S., Ritzenthaler J. D., Zheng Y., Roman J., PPAR / agonist stimulates human lung carcinoma cell growth through inhibition of PTEN expression: the involvement of PI3K and NF- B signals American Journal of Physiology 2008 294 6 L1238 L1249
67. Di-Po N., Tan N. S., Michalik L., Wahli W., Desvergne B., Antiapoptotic role of PPAR in keratinocytes via transcriptional control of the Akt1 signaling pathway Molecular Cell 2002 10 4 721 733 (Pubitemid 35335629)
68. Pedchenko T. V., Gonzalez A. L., Wang D., DuBois R. N., Massion P. P., Peroxisome proliferator-activated receptor / expression and activation in lung cancer American Journal of Respiratory Cell and Molecular Biology 2008 39 6 689 696
69. Michalik L., Desvergne B., Tan N. S., Basu-Modak S., Escher P., Rieusset J., Peters J. M., Kaya G., Gonzalez F. J., Zakany J., Metzger D., Chambon P., Duboule D., Wahli W., Impaired skin wound healing in peroxisome proliferator-activated receptor (PPAR) and PPAR mutant mice Journal of Cell Biology 2001 154 4 799 814 (Pubitemid 34292961)
70. Shi Y., Hon M., Evans R. M., The peroxisome proliferator-activated receptor, an integrator of transcriptional repression and nuclear receptor signaling Proceedings of the National Academy of Sciences of the United States of America 2002 99 5 2613 2618 (Pubitemid 34240509)
71. Sarraf P., Mueller E., Jones D., King F. J., DeAngelo D. J., Partridge J. B., Holden S. A., Chen L. B., Singer S., Fletcher C., Spiegelman B. M., Differentiation and reversal of malignant changes in colon cancer through PPAR Nature Medicine 1998 4 9 1046 1052 (Pubitemid 28417337)
72. Cheon C. W., Kim D. H., Kim D. H., Cho Y. H., Kim J. H., Effects of ciglitazone and troglitazone on the proliferation of human stomach cancer cells World Journal of Gastroenterology 2009 15 3 310 320
73. He Q., Pang R., Song X., Chen J., Chen H., Chen B., Hu P., Chen M., Rosiglitazone suppresses the growth and invasiveness of SGC-7901 gastric cancer cells and angiogenesis in vitro via PPAR dependent and independent mechanisms PPAR Research 2008 2008 9
74. Takashima T., Fujiwara Y., Hamaguchi M., Sasaki E., Tominaga K., Watanabe T., Oshitani N., Higuchi K., Arakawa T., Relationship between peroxisome proliferator-activated receptor-gamma expression and differentiation of human esophageal squamous cell carcinoma Oncology Reports 2005 13 4 601 606
75. Slomiany B. L., Piotrowski J., Slomiany A., Gastric mucosal inflammatory responses to Helicobacter pylori lipopolysaccharide: suppression of caspase-3 and nitric oxide synthase-2 by omeprazole and sucralfate Inflammopharmacology 1999 7 2 163 177 (Pubitemid 29404202)
76. Delerive P., De Bosscher K., Besnard S., Vanden Berghe W., Peters J. M., Gonzalez F. J., Fruchart J. C., Tedgui A., Haegeman G., Staels B., Peroxisome proliferator-activated receptor negatively regulates the vascular inflammatory gene response by negative cross-talk with transcription factors NF- B and AP-1 Journal of Biological Chemistry 1999 274 45 32048 32054